Affiliations
AffiliationsItem in Clipboard
The past, present, and future of cancer incidence in the United States: 1975 through 2020Hannah K Weir et al. Cancer. 2015.
. 2015 Jun 1;121(11):1827-37. doi: 10.1002/cncr.29258. Epub 2015 Feb 3. AffiliationsItem in Clipboard
AbstractBackground: The overall age-standardized cancer incidence rate continues to decline whereas the number of cases diagnosed each year increases. Predicting cancer incidence can help to anticipate future resource needs, evaluate primary prevention strategies, and inform research.
Methods: Surveillance, Epidemiology, and End Results data were used to estimate the number of cancers (all sites) resulting from changes in population risk, age, and size. The authors projected to 2020 nationwide age-standardized incidence rates and cases (including the top 23 cancers).
Results: Since 1975, incident cases increased among white individuals, primarily caused by an aging white population, and among black individuals, primarily caused by an increasing black population. Between 2010 and 2020, it is expected that overall incidence rates (proxy for risk) will decrease slightly among black men and stabilize in other groups. By 2020, the authors predict annual cancer cases (all races, all sites) to increase among men by 24.1% (-3.2% risk and 27.3% age/growth) to >1 million cases, and by 20.6% among women (1.2% risk and 19.4% age/growth) to >900,000 cases. The largest increases are expected for melanoma (white individuals); cancers of the prostate, kidney, liver, and urinary bladder in males; and the lung, breast, uterus, and thyroid in females.
Conclusions: Overall, the authors predict cancer incidence rates/risk to stabilize for the majority of the population; however, they expect the number of cancer cases to increase by >20%. A greater emphasis on primary prevention and early detection is needed to counter the effect of an aging and growing population on the burden of cancer.
Keywords: cancer; cancer registries; incidence; predictions; projections; surveillance.
© 2015 American Cancer Society.
FiguresFigure 1
(a-d) Trends in incident cases…
Figure 1
(a-d) Trends in incident cases for all cancers and ages combined attributed to…
Figure 1(a-d) Trends in incident cases for all cancers and ages combined attributed to population risk and diagnostic practices, growth, and aging are shown. Surveillance, Epidemiology, and End Results SEER 9 registry data (1975-2009) are shown by sex and race (white vs black) in (a) white males, (b) white females, (c) black males, and (d) black females.
Figure 2
(a-m) Trends in observed (solid…
Figure 2
(a-m) Trends in observed (solid line) and predicted (dotted line) age-standardized incidence rates…
Figure 2(a-m) Trends in observed (solid line) and predicted (dotted line) age-standardized incidence rates are shown for all sites combined and the top 10 cancers in men and women with the largest predicted increase in incident cases (white and black individuals), 1975 through 2020. NOS indicates not otherwise specified; IBD, inflammatory bowel disease.
Figure 2
(a-m) Trends in observed (solid…
Figure 2
(a-m) Trends in observed (solid line) and predicted (dotted line) age-standardized incidence rates…
Figure 2(a-m) Trends in observed (solid line) and predicted (dotted line) age-standardized incidence rates are shown for all sites combined and the top 10 cancers in men and women with the largest predicted increase in incident cases (white and black individuals), 1975 through 2020. NOS indicates not otherwise specified; IBD, inflammatory bowel disease.
Figure 3
(a and b) Cancer site-specific…
Figure 3
(a and b) Cancer site-specific incident cases predicted to be diagnosed in 2010…
Figure 3(a and b) Cancer site-specific incident cases predicted to be diagnosed in 2010 (dark shading) and additional cases predicted to be diagnosed in 2020 (lighter shading) are shown ranked by 2010 case counts by sex. CNS indicates central nervous system; IBD, inflammatory bowel disease.
Similar articlesWeir HK, Thompson TD, Stewart SL, White MC. Weir HK, et al. Prev Chronic Dis. 2021 Jun 10;18:E59. doi: 10.5888/pcd18.210006. Prev Chronic Dis. 2021. PMID: 34114543 Free PMC article.
Cronin KA, Lake AJ, Scott S, Sherman RL, Noone AM, Howlader N, Henley SJ, Anderson RN, Firth AU, Ma J, Kohler BA, Jemal A. Cronin KA, et al. Cancer. 2018 Jul 1;124(13):2785-2800. doi: 10.1002/cncr.31551. Epub 2018 May 22. Cancer. 2018. PMID: 29786848 Free PMC article.
Simard EP, Ward EM, Siegel R, Jemal A. Simard EP, et al. CA Cancer J Clin. 2012 Mar-Apr;62(2):118-28. doi: 10.3322/caac.20141. Epub 2012 Jan 4. CA Cancer J Clin. 2012. PMID: 22281605 Review.
Canto MT, Chu KC. Canto MT, et al. Cancer. 2000 Jun 1;88(11):2642-52. doi: 10.1002/1097-0142(20000601)88:11<2642::aid-cncr29>3.0.co;2-s. Cancer. 2000. PMID: 10861444
Weir HK, Thun MJ, Hankey BF, Ries LA, Howe HL, Wingo PA, Jemal A, Ward E, Anderson RN, Edwards BK. Weir HK, et al. J Natl Cancer Inst. 2003 Sep 3;95(17):1276-99. doi: 10.1093/jnci/djg040. J Natl Cancer Inst. 2003. PMID: 12953083 Review.
Kong LL, Man DM, Wang T, Zhang GA, Cui W. Kong LL, et al. Oncol Lett. 2016 Apr;11(4):2475-2480. doi: 10.3892/ol.2016.4244. Epub 2016 Feb 18. Oncol Lett. 2016. PMID: 27073501 Free PMC article.
Fash DM, Peer CJ, Li Z, Talisman IJ, Hayavi S, Sulzmaier FJ, Ramos JW, Sourbier C, Neckers L, Figg WD, Beutler JA, Chain WJ. Fash DM, et al. Bioorg Med Chem Lett. 2016 Jun 1;26(11):2641-4. doi: 10.1016/j.bmcl.2016.04.016. Epub 2016 Apr 8. Bioorg Med Chem Lett. 2016. PMID: 27107948 Free PMC article.
Assumpção JAF, Pasquarelli-do-Nascimento G, Duarte MSV, Bonamino MH, Magalhães KG. Assumpção JAF, et al. J Biomed Sci. 2022 Feb 14;29(1):12. doi: 10.1186/s12929-022-00796-0. J Biomed Sci. 2022. PMID: 35164764 Free PMC article. Review.
Ballerini P, Dovizio M, Bruno A, Tacconelli S, Patrignani P. Ballerini P, et al. Front Pharmacol. 2018 Feb 2;9:66. doi: 10.3389/fphar.2018.00066. eCollection 2018. Front Pharmacol. 2018. PMID: 29456511 Free PMC article. Review.
Ryan AT, Pulukuri AJ, Davaritouchaee M, Abbasi A, Hendricksen AT, Opp LK, Burt AJ, Nielsen AE, Mancini RJ. Ryan AT, et al. Acta Pharmacol Sin. 2020 Jul;41(7):995-1004. doi: 10.1038/s41401-020-0432-4. Epub 2020 May 25. Acta Pharmacol Sin. 2020. PMID: 32451412 Free PMC article.
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.3